diabetes header graphic


Diabetes Nutrition Secrets
By Brue

If you have been diagnosed with diabetes, your food selections become even more important, since nutrition can have an even greater impact on your health.

Healthy food choices are important for our nutrition. In order for all of us to feel better, maintain a healthy weight and be protected from diseases and other harmful conditions we need to pay close attention to what we put into our bodies. However, if you have been diagnosed with diabetes, your food selections become even more important, since nutrition can have an even greater impact on your health.

The good news is that nutrition is really not that different from the healthy food choices that the rest of the population should make. It simply becomes more important to make those choices carefully and consistently if you have this disease.

Watch your Percentages

As a general rule, nutrition should include a diet that consists of 20-40% of carbohydrates, 20-40% from protein, and 30% or less from fat. This should be measured by the amount of calories consumed and is good guideline for anyone with diabetes.

In addition to monitoring the correct percentages of the types of food you eat, it is also important to make good choices

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: Dapagliflozin;   Drug: Dapagliflozin;   Drug: Placebo<br/><b>Sponsors</b>:   Bristol-Myers Squibb;   AstraZeneca<br/><b>Not yet recruiting</b> - verified September 2010
Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes
<b>Condition</b>:   Type II Diabetes Mellitus<br/><b>Intervention</b>:   Drug: CM3.1-AC100<br/><b>Sponsor</b>:   CellMed AG, A Subsidiary of Biocompatibles International plc.<br/><b>Recruiting</b> - verified September 2010
Euglycemic Clamp Dose-response Study Comparing Insulin Glargine U300 With Lantus® U100
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Insulin glargine (HOE901);   Drug: Insulin glargine (HOE901)<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified September 2010
Efficacy of Adding Sitagliptin or Pioglitazone to T2DM Insufficiently Controlled With Metformin and Sulfonylurea
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: Sitagliptin;   Drug: pioglitazone<br/><b>Sponsor</b>:   Mackay Memorial Hospital<br/><b>Recruiting</b> - verified September 2010
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: HUMAN INSULIN (BIOSYNTHETIC);   Drug: Insuplant<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified September 2010
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Placebo;   Drug: Linagliptin<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified September 2010
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Drug: Formoterol<br/><b>Sponsors</b>:   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified September 2010
An Open-randomized, Balanced, Crossover Bioequivalence Study to Compare One MR Tablet of 60 mg Gliclazide and Two MR Tablets of 30 mg Gliclazide in Healthy Subjects
<b>Conditions</b>:   Hyperglycemia;   Diabetes<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Taipei Medical University WanFang Hospital<br/><b>Recruiting</b> - verified September 2010
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Device: Diabetes Interactive Diary (DID)<br/><b>Sponsors</b>:   Consorzio Mario Negri Sud;   Sanofi-Aventis;   LifeScan<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type II<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
<b>Condition</b>:   Diabetic Macular Edema<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   University of Toronto;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified September 2010
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes: An Extension Trial to NN1250-3579
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With or Without Metformin and With/Without Pioglitazone in Type 2 Diabetes: An Extension Trial to NN1250-3582
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified September 2010
BI 10773 Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: Placebo<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Bristol-Myers Squibb;   AstraZeneca<br/><b>Active, not recruiting</b> - verified August 2010
A Study of OPC-262 in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes, Type 2<br/><b>Intervention</b>:   Drug: OPC-262<br/><b>Sponsor</b>:   Otsuka Pharmaceutical Co., Ltd.<br/><b>Recruiting</b> - verified August 2010
Clinical Trial Evaluating the Efficacy and Safety of Technosphere Insulin Inhalation Power Using the Gen2 Inhaler
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: Technosphere Insulin;   Drug: Insulin Aspart;   Drug: Glargine<br/><b>Sponsor</b>:   Mannkind Corporation<br/><b>Not yet recruiting</b> - verified September 2010
Glycemic Holter Study (Continuous Glucose Monitoring) -
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Vildagliptin;   Drug: Sitagliptin<br/><b>Sponsor</b>:   Novartis<br/><b>Recruiting</b> - verified August 2010
Malignancy Meta Analysis for BRL49653
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   Drug: allocation of treatment with metformin or rosiglitazone<br/><b>Sponsor</b>:   GlaxoSmithKline<br/><b>Completed</b> - verified September 2010
Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Behavioral: psychosocial intervention<br/><b>Sponsor</b>:   Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified August 2010
Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Intervention</b>:   Drug: vildagliptin/metformin<br/><b>Sponsor</b>:   Novartis<br/><b>Recruiting</b> - verified September 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: metformin XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: Glucophage XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Insulin Glargine;   Drug: LY2189266<br/><b>Sponsor</b>:   Eli Lilly and Company<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin detemir (Levemir®);   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified September 2010
Exploratory Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus and Secondary Hypogonadism or Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
<b>Conditions</b>:   Type 2 Diabetes Mellitus;   Secondary Hypogonadism<br/><b>Interventions</b>:   Drug: Placebo;   Drug: enclomiphene citrate<br/><b>Sponsor</b>:   Repros Therapeutics Inc.<br/><b>Not yet recruiting</b> - verified September 2010
Dietary Intervention With Shop Model - SHOPUS
<b>Condition</b>:   Obesity<br/><b>Intervention</b>:   Behavioral: Dietary intervention<br/><b>Sponsor</b>:   University of Copenhagen<br/><b>Recruiting</b> - verified July 2010
Adipose Tissue Gene Expression Profiles in Women With Polycystic Ovary Syndrome (PCOS) Versus Controls
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   The Adelaide and Meath Hospital;   University College Dublin<br/><b>Completed</b> - verified July 2008
Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   The Adelaide and Meath Hospital;   University College Dublin<br/><b>Completed</b> - verified July 2008
A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Diabetic and Hypertensive Filipinos
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   Drug: Bisoprolole<br/><b>Sponsor</b>:   Merck KGaA<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
<b>Condition</b>:   Arterial Hypertension<br/><b>Interventions</b>:   Drug: Chlorthalidone 25 mg + amiloride hydrochloride 5 mg;   Drug: Higroton® Laboratório Novartis<br/><b>Sponsor</b>:   Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified August 2010
Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone
<b>Condition</b>:   Infant, Small for Gestational Age<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Merck KGaA<br/><b>Enrolling by invitation</b> - verified September 2010


within those percentages. For example, opt for organic fruits and vegetables from the health food store instead of the chemical laden kind you get at the supermarket.

Go with a skinless chicken breast rather than a piece of red meat as often as possible. By consistently acting in a conscientious manner when planning your menus and making your food selections, you will go far in keeping your nutrition where it should be.

What to Include In Your Diet

Diabetes nutrition is not that different from nutrition for everyone else, so stick with the standard guidelines of nutrition and you will go far in helping to manage your disease. If you are overweight, you will also want to opt for low-calorie and low-fat foods that will help you to drop the excess pounds and maintain a healthier weight. Always remember to drink a lot of water.

Along with organic fruits and vegetables being at the top of your nutrition list, you may want to add plenty of whole grains that will offer the necessary fiber and nutrients. Your protein selections should be of the lean and low-fat varieties.

Try soy protein as plant based protein is better for you than animal based protein. Animal based protein comes from meat that you consume. If you insist on eating meat try to add wild fish and beans instead of red meat whenever possible to meet your requirements.

What to Avoid In Your Diet

Like any healthy diet program, nutrition consists of keeping foods high in fat and sugar to a minimum for both weight control and nutritional considerations. Although most medical professionals will agree that a little sugar is not necessarily a bad thing when it comes to nutrition, too much of a good thing can become a problem rather quickly.

Therefore, it is important to limit your intake of refined sugar items as well as those that are fried or high in fat from other sources. Stay away from all processed foods (fast food, potato chips, candy etc.) They have no nutritional content whatsoever.

Keep in mind that even healthy foods contain calories, so it is also important to monitor portion sizes as a part of nutrition.




Here are some more diabetes articles...

What You Got To Know About Acid Flex In Infants
By Cindy Heller
Infant or newborn acid reflux is the scientific term used when a baby throws up. This is a familiar condition that is experienced by infants under the age of 12 months, due to the lower esophageal Read more...
Hair Vitamins - Mens Vitamins - Liquid Vitamins 537
By robbyknobby
Liquid life supplements check all the essential nutrients required by your body. This increase contains more than a few , electrolytes and . Liquid life contains minerals Read more...